Abstract
A Phase 3 Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas (RTOG 0129): Long-term Report of Efficacy and Toxicity
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have